Clayton Financial Group’s AbbVie ABBV Stock Holding History

Clayton Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Hold	6,966	–	–	0.78%	20
2025 Q4	$1.59M	Buy	6,966 +794	+13%	+$181K	0.81%	20
2025 Q3	$1.43M	Buy	+6,172	New	+$1.26M	1.04%	15
2025 Q2	–	Sell	-3,628	Closed	-$760K	–	30
2025 Q1	$760K	Hold	3,628	–	–	0.28%	53
2024 Q4	$645K	Hold	3,628	–	–	0.23%	61
2024 Q3	$716K	Buy	3,628 +1,723	+90%	+$322K	0.27%	55
2024 Q2	$347K	Hold	1,905	–	–	0.15%	71
2024 Q1	$347K	Buy	+1,905	New	+$328K	0.16%	70

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clayton Financial Group's ABBV Position: Q1 2026 in Review

Clayton Financial Group held its AbbVie (ABBV) position steady in Q1 2026 at 6,966 shares worth $1.52M. The position accounts for 0.78% of the portfolio, ranked #20.

Clayton Financial Group first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.59M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Clayton Financial Group held 6,966 shares of AbbVie worth $1.52M as of Q1 2026.
Clayton Financial Group left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.78% of Clayton Financial Group's portfolio in Q1 2026, its #20 holding.
Clayton Financial Group first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
Clayton Financial Group's AbbVie position peaked at $1.59M in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Clayton Financial Group's 13F filing for Q1 2026, filed 13 Apr 2026.